(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LUPUS THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LUPUS THERAPEUTICS

ST13

US500000088159324

Class

35, 36

Filing

88159324

Registration

6248308

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

51

Latest update

02/20/2026

Trademark type

Combined

Nice classes

35, 36

Filing date

10/17/2018

Registration date

01/19/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/19/2021

Last transaction

02/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

07/19/2018

First use in commerce

07/19/2018

Drawing code

3

Owner type

03

Owner location

NEW YORK, NY, US

Examiner

OPUTA, CHIOMA N

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a design of connected dots in a diamond shape. The word "LUPUS" appears to the right of the design with the word "THERAPEUTICS" under and to the right of that.

Holders and representatives

Holders

Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc.

Representatives

Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 35Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consultation services for clinical trials and clinical research in the field of lupus erythematosus and related illnesses

Class 36

providing grants for medical research; providing financial support for clinical research in the field of lupus erythematosus and related illnesses

Publications

History of USPTO decisions and trademark events.

51 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/18/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/18/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/18/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/18/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/18/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/19/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/18/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/18/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/18/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/18/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/24/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/24/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/24/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/24/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/24/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/19/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/03/2020

PUBO

PUBLISHED FOR OPPOSITION

11/03/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/14/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/29/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

09/29/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/29/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

09/29/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/29/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/15/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/15/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/15/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/19/2020

GNFR

FINAL REFUSAL E-MAILED

03/19/2020

CNFR

FINAL REFUSAL WRITTEN

03/19/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/25/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/24/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/24/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/24/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/24/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/24/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/24/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/24/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/22/2019

GNRT

NON-FINAL ACTION E-MAILED

08/22/2019

CNRT

NON-FINAL ACTION WRITTEN

08/22/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/31/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/30/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/30/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/01/2019

GNRT

NON-FINAL ACTION E-MAILED

02/01/2019

CNRT

NON-FINAL ACTION WRITTEN

02/01/2019

DOCK

ASSIGNED TO EXAMINER

01/26/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/30/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/29/2018

NWAP

NEW APPLICATION ENTERED

10/20/2018

Continuous trademark protection

Get notified about every new filing that threatens LUPUS THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.